Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
Over the past few decades, immune checkpoint inhibitors (ICIs) have emerged as promising therapeutic options for the treatment of various cancers. These novel treatments effectively target key mediators of immune checkpoint pathways. Currently, ICIs primarily consist of monoclonal antibodies that sp...
| Main Authors: | , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
MDPI AG
2023-07-01
|
| 叢編: | Current Oncology |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/1718-7729/30/7/498 |